Silexion Therapeutics (SLXN) announced compelling preclinical data demonstrating the efficacy of its next-generation RNAi therapeutic candidate, SIL204, against human pancreatic, colorectal and ...

A high-level overview of Silexion Therapeutics Corp (SLXN) stock. View (SLXN) real-time stock price, chart, news, analysis, analyst reviews and more.

A high-level overview of Silexion Therapeutics Corp Wt Exp (SLXNW) stock. View (SLXNW) real-time stock price, chart, news, analysis, analyst reviews and more.

Find out all the key statistics for Silexion Therapeutics Corp (SLXN), including valuation measures, fiscal year financial statistics, trading record, share statistics and more.

Silexion Therapeutics Corp OverviewBiotechnology / Healthcare Silexion Therapeutics Corp, a biopharmaceutical company, discovers and develops RNA interference (RNAi)-based cancer drugs and delivery ...

Discover how digital therapeutics (DTx) have evolved in the wake of COVID-19, and how they are changing the landscape of healthcare. Explore the fall and rise of DTx and their potential impact on ...